(c) 2024 PillSync.com

ezetimibe 10 mg simvastatin 20 mg

1 INDICATIONS AND USAGE Ezetimibe and simvastatin tablets Ezetimibe and simvastatin tablet is a combination of simvastatin and ezetimibe indicated: As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce elevated LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simv a statin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. Ezetimibe and simvastatin tablet is a combination of ezetimibe, a dietary cholesterol absorption inhibitor, and simvastatin, an HMG-CoA reductase inhibitor (statin) indicated: ( 1 ) As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C lowering therapies to reduce LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events.

aurobindo pharma limited


6 months ago OVAL WHITE TS 2 ezetimibe 10 mg simvastatin 20 mg

OVAL WHITE TS 2

16 HOW SUPPLIED/STORAGE AND HANDLING

EZETIMIBE AND SIMVASTATIN Tablets are available containing 10 mg of ezetimibe, USP and 10 mg, 20 mg, 40 mg or 80 mg of simvastatin, USP, providing for the following combinations: 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg or 10 mg/80 mg. The 10 mg/10 mg tablets are white, oval, biconvex tablets debossed with “TS†on one side of the tablet and “1†on the other side. They are available as follows: Bottles of 30 NDC 59651-835-30 Bottles of 90 NDC 59651-835-90 The 10 mg/20 mg tablets are white, oval, biconvex tablets debossed with “TS†on one side of the tablet and “2†on the other side. They are available as follows: Bottles of 30 NDC 59651-836-30 Bottles of 90 NDC 59651-836-90 The 10 mg/40 mg tablets are white, oval, biconvex tablets debossed with “TS†on one side of the tablet and “3†on the other side. They are available as follows: Bottles of 30 NDC 59651-837-30 Bottles of 90 NDC 59651-837-90 The 10 mg/80 mg tablets are white, oval, biconvex tablets debossed with “TS†on one side of the tablet and “4†on the other side. They are available as follows: Bottles of 30 NDC 59651-838-30 Bottles of 90 NDC 59651-838-90 Storage Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed.


More pills like OVAL TS 2












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site